top of page
Arblast USA
Evidence: Motohiro Kasahara's identity spoofing / fabrication document
Motohiro Kasahara forged his identity as a corporate lawyer to steal our patents and submitted a forged document to the German and American Patent Ministry. For this reason, American and overseas shareholders who learned of this fact said, "What's going on? ], An angry phone call continued. In other words, Motohiro Kasahara, Yoshiko Nakajima of the Kobe Advanced Medical Promotion Foundation, and JCR Farmer were involved in patent fraud, and by learning about this crime, we are said to be about 700 million yen or 2 billion yen for Stemcell Science Co., Ltd. in Kobe. Following the thesis forgery fraud of the Advanced Medical Promotion Foundation and the Institute of Physical and Chemical Research (STAP cell group), we waited with evidence of crimes related to the Advanced Medical Promotion Foundation in Kobe. Click here for more information on the treatise forgery fraud of Stem Cell Science Co., Ltd.
For whatever reason, it is a crime to submit a forged document. Is it okay for a lawyer to openly send such a forged document to an overseas patent ministry? There is no good reason. An American lawyer told me that what Motohiro Kasahara and his colleagues did was just a patent fraud. It doesn't matter at any time, so please file a complaint. It is also said to be. I think it's natural.
The attached document on the right is forged by Motohiro Kasahara ( famous as a patent lawyer ) who is a lawyer of Zen Kitagawa and Shigeru Kinoshita on August 29, 2011, in order to hijack the patent of Arblast USA's keratin regeneration sheet. It is a forged document of evidence that describes the fact that the document was prepared and submitted to a German patent attorney.
Motohiro Kasahara is also a lawyer for Chimaki Furusawa (Turkish name Ous Memet), a former director of Stem Cell Science, who filed a lawsuit against me and my husband in a forgery trial, and at the same time filed for bankruptcy of Kitagawa. He is also a lawyer.
It was the two lawyers who paid for the patent, which was aimed at this patent [Kitakawa is aiming like a hyena . ] I will be JCR Farmer with Yoshiko Nakajima of the Advanced Medical Promotion Foundation in Kobe.
Also, it seems that Motohiro Kasahara is originally a lawyer for a fraudulent organization that holds a patent, but if you search for Motohiro Kasahara on the Internet, you will find many bad rumors. I can't judge whether it is true or not, so I won't describe it here, but I'm surprised that the patent hijacking is very similar to the content and method of the patent hijacking by Alblast USA. it was done.
As far as I know, Motohiro Kasahara's patent hijacking method, as you can see from the document below, is to forge a document by misrepresenting himself, as if he were an official of Arblast USA. You can see that it is forged and patented.
1. In this document below, Zen Kitagawa is the representative director of Alblast. Is written. However, Zen Kitagawa is no longer the president at this point. I was on leave with a medical certificate. Who is the lawyer who has requested a leave of absence because he is in a state of dementia along with the medical certificate and cannot do any work? It was Motohiro Kasahara.
2. Inoue is not a director or a representative, but Mr. Inoue is lying in this document. Is written. It is as if Mr. Inoue is calling himself a director even though the general meeting of shareholders has not been approved by the board of directors. However, at this point, Mr. Inoue is undoubtedly the representative director and manager approved at the general meeting of shareholders and the board of directors. Of course, Kasahara is familiar with that fact. As proof of this, you can see the fact that Kasahara himself clearly states "Director Inoue" in the address of the email sent from Kasahara to Mr. Inoue.
3. There is no contract in this document that the patent has been assigned. Although the content is written, this is also a complete fabrication.
Alblast and Alblast USA have entered into a business transfer agreement.
Evidence that the patent is clearly an Arblast USA patent
bottom of page